SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007084
Filing Date
2019-08-05
Accepted
2019-08-05 16:31:33
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tbph-20190630x10q.htm   iXBRL 10-Q 2024612
2 EX-10.1 tbph-20190630ex1017d2103.htm EX-10.1 41938
3 EX-10.2 tbph-20190630ex102a8169b.htm EX-10.2 108835
4 EX-31.1 tbph-20190630ex311fce379.htm EX-31.1 14916
5 EX-31.2 tbph-20190630ex3129eb423.htm EX-31.2 15700
6 EX-32 tbph-20190630xex32.htm EX-32 17725
7 GRAPHIC tbph20190630ex1017d2103001.jpg GRAPHIC 3527
  Complete submission text file 0001558370-19-007084.txt   6826424

Data Files

Seq Description Document Type Size
8 EX-101.SCH tbph-20190630.xsd EX-101.SCH 43629
9 EX-101.CAL tbph-20190630_cal.xml EX-101.CAL 51393
10 EX-101.DEF tbph-20190630_def.xml EX-101.DEF 153177
11 EX-101.LAB tbph-20190630_lab.xml EX-101.LAB 414290
12 EX-101.PRE tbph-20190630_pre.xml EX-101.PRE 308350
13 EXTRACTED XBRL INSTANCE DOCUMENT tbph-20190630x10q_htm.xml XML 1060735
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 19999072
SIC: 2834 Pharmaceutical Preparations